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Background: E-selectin is implicated in various inflammatory processes and related disorders. We aimed to
investigate the role of SELE-gene genotypes/haplotypes on plasma levels of MMP9 and sE-selectin in Taiwanese
individuals.
Methods: Five hundred twenty individuals were enrolled. Seven tagging SELE single nucleotide polymorphisms
were analyzed.
Results: SELE genotypes were found associated with MMP9 and sE-selectin levels. Multivariate analysis identified
that the most significant genetic polymorphism (rs5368 genotype) was independently associated with MMP9 levels
(P < 0.001). One haplotype (GGAGAGT) was marginally associated with MMP9 levels (P = 0.0490). One SELE SNP,
(rs3917406, P = 0.031) was associated with sE-selectin levels after adjusting for MMP9 and sICAM1 levels. Subgroup
and interaction analysis revealed association of SELE SNP rs10800469 with sE-selectin levels only in the highest
quartile of MMP9 level (P = 0.002, interaction P = 0.023). Haplotype analysis showed one haplotype (AAAAAGC)
borderline associated with sE-selectin level (P = 0.0511).
Conclusion: SELE genotypes/haplotypes are independently associated with MMP9 and E-selectin levels in
Taiwanese individuals. The associations of SELE genotypes/haplotypes with sE-selectin levels are affected by
MMP9 levels.
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Chronic inflammation plays an import role in a variety
of pathological disorders, including chronic pulmonary
disease, chronic renal disease, and cardiovascular disease
[1-3]. Chronic inflammation is also associated with
abdominal obesity, smoking, and physical inactivity. The
process of inflammation involves the interplay of many
pro-inflammatory markers including C-reactive protein,
fibrinogen, cytokines, adhesive molecules, and proteases
[1,4]. E-selectin, an endothelial adhesive molecule, is a* Correspondence: yulinkotw@yahoo.com.tw
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reproduction in any medium, provided the orglycoprotein expressed exclusively on endothelial cells in
response to inflammatory cytokines. It mediates the
interaction of circulating leukocytes in various physio-
logical and pathological settings [5]. E-selectin is also
involved in activation of intracellular signaling pathways
involved in the trans-endothelial migration of leukocytes
[6]. Leukocyte and endothelial interactions contribute to
a variety of vascular disease processes, such as acute
and chronic inflammation and atherosclerosis. Soluble
E-selectin (sE-selectin), thought to be shed from acti-
vated endothelial cells, has also been associated with
atherosclerosis [7].
Single nucleotide polymorphisms (SNPs) of the SELE
gene, encoding the E-selectin protein, have been linked
to various disease states. The Ser128Arg gene variant,
the most commonly reported SELE-gene polymorphism,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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coronary artery disease, venous thrombosis, ischemic
cerebral vascular disease, postoperative myocardial in-
farction, prognosis of colorectal cancer, restenosis after
successful coronary angioplasty, severity of atheroscler-
otic arterial disease, peripheral arterial occlusive disease,
and coronary calcification [8-12]. Common variants of
the SELE gene have also been found associated with the
susceptibility to either Graves’ disease or hypertension
[13-15]. However, the association between SELE SNPs
and E-selectin levels has been controversial [15-17], and
the association between SELE SNPs and other inflamma-
tory marker levels has not been reported. This investiga-
tion aimed to elucidate the association between SELE




A total of 520 study participants were enrolled for study
(mean ± SD): 264 men, age = 43.9 ± 9.4 years; 256
women, age = 45.8 ± 9.4 years. They responded to a
questionnaire on their medical history and lifestyle char-
acteristics, and were recruited during routine health
examinations between October 2003 and September
2005 at the Chang Gung Memorial Hospital. AllTable 1 Baseline characteristics of the study subjects
Total
Number 520
Age (years) 44.8 ± 9.4
Systolic BP (mm Hg) 112.8 ± 16.1
Diastolic BP (mm Hg) 75.0 ± 10.0
Total cholesterol (mg/dL) 199.4 ± 36.2
HDL-cholesterol (mg/dL) 55.8 ± 14.5
LDL-cholesterol (mg/dL) 116.7 ± 33.1
Triglycerides (mg/dL) 139.0 ± 111.4
Body mass index (kg/m2) 24.1 ± 3.4
Waist circumference (cm) 84.5 ± 9.5
Current smokers (%) 19.8
Diabetes mellitus (%) 2.5
Glucose (AC) (mg/dL) 95.5 ± 22.3
HOMA-IR index 2.2 ± 1.4
CRP (mg/L) 1.0 ± 1.4
Fibrinogen (mg/dL) 260.2 ± 66.7
sE-selectin (ng/mL) 52.5 ± 25.7
sICAM1 (ng/mL) 239.8 ± 113.2
MMP9 (ng/mL) 141.9 ± 111.8
BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CRP,
sE-selectin, soluble E-selectin; MMP9, matrix metalloproteinase 9; Continuous variabl
were transformed logarithmically before statistical testing to meet the assumptionparticipants provided written informed consent. Exclu-
sion criteria included cancer, current renal or liver dis-
ease, and a history of myocardial infarction, stroke, or
transient ischemic attacks. In addition, individuals with a
history of regular use of medication for diabetes melli-
tus, hypertension and/or lipid-lowering drugs were
excluded from the analysis, because previous reports
revealed that these agents affect the expression or
concentrations of inflamatory markers [18-20]. The cli-
nical and biometric features of the study group are sum-
marized in Table 1. Hypertension was defined as a
systolic blood pressure (BP) ≥ 140 mmHg and/or dia-
stolic BP ≥ 90 mmHg, or regular use of antihypertensive
medication. Obesity was defined as a body mass index
(BMI) ≥ 25 kg/m2, according to the Asian criteria [21].
Current smokers were defined as individuals who
smoked at least one cigarette per day at the time of the
survey. The study was approved by the Ethics Commit-
tee of the Tzu-Chi Memorial Hospital.
Laboratory examination
Before starting the study, all participants underwent an
initial screening assessment that included medical his-
tory, vital signs, a 12-lead electrocardiogram, and mea-
surement of lipid variables and novel risk factors. A total
of 15 mL of venous blood was collected in the morningMen Women P value
264 256
43.9 ± 9.4 45.8 ± 9.4 0.023
113.8 ± 14.3 111.8 ± 17.8 0.172
77.0 ± 9.8 73.0 ± 9.9 < 0.001
202.7 ± 36.2 196.1 ± 36.0 0.036
49.9 ± 12.1 62.0 ± 14.1 < 0.001
120.5 ± 34.3 112.8 ± 31.5 0.008
170.1 ± 137.6 107.0 ± 60.7 < 0.001
24.8 ± 3.1 23.4 ± 3.6 < 0.001
87.5 ± 7.6 81.4 ± 10.3 < 0.001
35.2 3.9 < 0.001
2.7 2.4 0.526
97.9 ± 25.6 93.1 ± 17.9 0.014
2.3 ± 1.6 2.0 ± 1.1 0.002
1.1 ± 1.4 1.0 ± 1.3 0.060
257.7 ± 68.6 262.8 ± 64.7 0.381
59.8 ± 27.0 45.0 ± 22.0 < 0.001
243.8 ± 109.6 235.8 ± 116.8 0.281
154.1 ± 112.8 129.4 ± 109.6 < 0.001
C-reactive protein; sICAM1, soluble intercellular adhesive molecule 1;
es are presented as mean ± SD. CRP, sICAM1, sE-selectin and MMP9 values
of normal distributions; however, the untransformed data are shown.
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samples were collected from an antecubital vein using a
21-gauge needle. Serum, EDTA, sodium fluoride, and so-
dium citrate plasma were obtained by centrifugation at
3000 × g for 15 minutes at 4°C. Immediately thereafter,
serum/plasma samples were frozen and stored at −80°C
prior to analysis. All measurements were performed in a
central laboratory. The homeostasis model assessment
of insulin resistance (HOMA-IR) index was calculated
using the formula: HOMA-IR = fasting serum insulin
(μU/mL) × fasting plasma glucose (mmol/L)/22.5.
Assays
Most markers, including C-reactive protein (CRP), sE-
selectin, sICAM-1 and MMP9 were measured using a
sandwich enzyme-linked immunosorbent assay (ELISA)
developed in-house. All in-house kits were compared
with commercially available ELISA kits and showed
good to excellent correlation [22-24]. Serum insulin
levels were measured using an immunoradiometric assay
(Bio-source, Nivelles, Belgium). Glucose was determined
enzymatically using the hexokinase method. Total chol-
esterol and triglyceride concentrations were measured
by automatic enzymatic colorimetry. High density lipo-
protein (HDL) cholesterol levels were measured enzyma-
tically after phosphotungsten/magnesium precipitation.
Low density lipoprotein (LDL) cholesterol was either
calculated from the Friedewald formula or, in patients
with triglycerides > 400 mg/dL, detected with commer-
cial reagents by standard protocol. Plasma fibrinogen
levels were determined using the Clauss method adapted
for a Sysmex CA1-1500 instrument in the Clinical
Hematology Laboratory.
Genomic DNA extraction and genotyping
Genomic DNA was extracted as reported previously
[25,26]. From the published sequence of the SELE gene,
oligonucleotide primers were generated to amplify
fragments of genomic DNA containing the genetic
polymorphisms reported on the websites of GenePipe
(http://genepipe.ngc.sinica.edu.tw/visualsnp) and the NCBI
SNP database (http://www.ncbi.nlm.nih.gov/SNP). Seven
SNPs within SELE were chosen in this study (Additional
file 1: Table S1). Six tagSNPs were chosen according to
a previous study reported by Chen et al. [15], who
selected tagSNPs by running the tagger program imple-
mented in Haploview software. The SNP rs5361
(Ser128Arg) was selected because it was located in an
exon, resulted in an amino-acid substitution and has
been linked to a wide variety of disorders [8-12]. Geno-
typing for the SNPs rs5368, rs3917412, and rs5361 was
performed using polymerase chain reaction and restric-
tion enzyme digestion. Genotyping for the SNPs
rs10800469, rs3917406, rs2179172, and rs3917419 wereperformed using TaqMan SNP Genotyping Assays
obtained from Applied Biosystems (ABI, Foster City,
CA, USA).
Statistical analysis
To determine the association between gender and other
clinical data, we used chi-square test and two-sided
t-test for categorical variables and continuous variables,
respectively. The clinical characteristics that were con-
tinuous variables are expressed as means ± SDs and
were tested using a two-sided t-test or analysis of vari-
ance (ANOVA). Furthermore, a general linear model
was applied to capture the major effect of each poly-
morphism on clinical phenotype variables, with BMI,
age, gender and smoking status as confounding covari-
ates. We used recessive models for numeric association
test after recoding our SNPs from categorical variables
to continuous variables, such as 0, 1 of a particular al-
lele. CRP, sICAM1, sE-selectin, sP-selectin, and MMP9
values were transformed logarithmically before analysis
to adhere to an assumption of normality. The result was
adjusted by false discovery rate (FDR) for multiple test
correction and the regression coefficient with FDR P
value <0.05 was considered as significant. Besides, step-
wise linear regression analysis was used to determine in-
dependent predictors of MMP9 levels. Interactions
between each SNP, the level of sE-selectin, and MMP9
levels were tested with two-way ANOVA. When inter-
action terms were found to be significant, stratified ana-
lyses of the genetic variants of the genotypes (e.g., target
genotypes affected by MMP9 levels) and sE-selectin level
were performed to further investigate interactive effects
while controlling for other variables including age, gen-
der, BMI, and smoking. All calculations were performed
with standard statistical SPSS software. For the assess-
ment of association between haplotypes and clinical vari-
ables, Golden Helix SVS Win32 7.3.1 software were
applied and the haplotype with FDR P value <0.05 was
reported. We used SNPStats software (available at
http://bioinfo.iconcologia.net/SNPstats) [27] to calculate
the linkage disequilibrium between SNPs and the
deviation from Hardy-Weinberg equilibrium. Values of
P < 0.05 using a two-sided test were considered statisti-
cally significant.
Results
Clinical and biochemical characteristics
A summary of demographic features, clinical and lipid
profiles, and inflammatory biomarkers for the study
participants stratified by gender is provided in Table 1.
No significant deviations from the Hardy-Weinberg
equilibrium were detected for the studied polymorphisms
(P = 0.73, 0.71, 0.17, 0.21, 0.88, 0.92, and 0.80 for SNPs
rs10800469, rs3917406, rs5361, rs3917412, rs2179172,
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were in strong pairwise linkage disequilibrium, except
for rs5361, for which the calculation was not pos-
sible due to the identification of only two of this geno-
type among the study participants (Additional file 1:
Table S2).
Associations of the SELE gene polymorphisms with serum
levels of MMP9 levels
Table 2 presents a comparison of the distributions of
the serum MMP9 concentrations according to SELE
genotype status. With the recessive model, the minor
alleles of rs3917419 and rs5368 were found to be associated
with higher MMP9 levels (P = 0.002 and P = 1.4 × 10-4,
respectively) after adjusting for age, gender, smoking
status, and BMI (Table 2). These associations
remained statistically significant after multiple com-
parisons adjustment (FDR P = 0.005 and P = 6.9 × 10-4,
respectively).
SELE haplotypes and MMP9 levels
Because the single SNP regression demonstrated that
multiple sites within the SELE gene significantly affect
MMP9 level, haplotypes were inferred to capture pos-
sible allelic associations. In the present investigation,
seven common haplotypes (≥ 1% frequency) were
derived from seven SNPs, accounting for 99.6% of all in-
ferred haplotypes (Table 3). In haplotype analysis, two
haplotypes inferred from seven SNPs (AAAAAGC andTable 2 Serum MMP9 and sE-selectin levels by SELE genotype
rs Number and Genotypes MMP9 P value#
(mg/L)
rs10800469 AA (n = 113) 143.0 ± 107.4 0.929
AG + GG (n =388) 141.9 ± 113.9
rs3917406 GG (n = 122) 159.4 ± 138.9 0.066
AA + AG (n = 378) 136.6 ± 102.0
rs5361 AA (n = 487) 142.9 ± 113.4 0.477**
AC (n = 12) 118.1 ± 62.7
CC (n = 0) -
rs3917412 AA (n = 40) 139.4 ± 84.5 0.964
AG + GG (n = 459) 142.6 ± 114.7
rs2179172 CC (n = 21) 137.8 ± 100.5 0.872
AA + AC (n = 476) 143.0 ± 113.1
rs3917419 AA (n = 15) 209.5 ± 119.3 0.002
AG + GG (n = 485) 139.4 ± 110.9
rs5368 TT (n = 25) 234.0 ± 209.9 1.1 × 10-4
CC + CT (n = 476) 137.0 ± 102.5
Continuous variables are presented as mean ± SD. MMP9 and sE-selectin values we
of normal distributions; however, the untransformed data are shown.
#Multiple linear regression, adjusted for age, gender, smoking and BMI. *Multiple lin
levels. Adjusted P values were computed by the false discovery rate method. **ComGGAGAGT) were found to be associated with either
decreased or increased MMP9 levels (P = 0.0234 and
P = 0.007, respectively). However, only the observed asso-
ciation between haplotype GGAGAGT and MMP9 levels
remained marginally significant after multiple compari-
sons adjustment (FDR P = 0.0490).
Stepwise regression analysis of MMP9 levels using a
general linear model in the study population
In addition to five previously reported independent
variables—age, current smoker, fibrinogen levels, fasting
plasma glucose level, and an MMP9 SNP rs2274756
[28]—the E-selectin gene variants were used for further
multivariate analysis. In a stepwise regression analysis,
the most significant genetic polymorphism rs5368 geno-
types with recessive model, age, gender, smoking status,
and fibrinogen levels were all independently associated
with MMP9 levels (P < 0.001) (Table 4).
Associations of the SELE genotypes/haplotypes with
sE-selectin levels: focus on interactive effects
In contrast to the highly significant association with
MMP9 levels, after the adjustment for age, gender,
smoking status, and BMI, there was a marginally signifi-
cant association of the SELE gene rs3917406 polymor-
phism with sE-selectin level (P = 0.023) (Table 2).
Because of the significant association of sE-selectin
levels with sICAM1, and MMP9 levels (r = 0.306,
P < 0.001 for sICAM1 and r = 0.177, P < 0.001 forin recessive model
Adjusted sE-selectin
(mg/L)
P value# P value* Adjusted
P value P value
1 55.0 ± 30.2 0.162 0.060 0.180
51.9 ± 24.3
0.131 49.0 ± 27.6 0.023 0.005 0.031
53.7 ± 25.1
- 52.6 ± 25.7 0.943** 0.865** -
56.3 ± 31.3
-
0.963 49.5 ± 19.7 0.624 0.824 0.824
52.9 ± 26.3
1 50.1 ± 24.9 0.772 0.492 0.590
52.9 ± 25.9
0.005 61.1 ± 47.2 0.326 0.224 0.336
52.4 ± 24.8
6.9 × 10-4 45.6 ± 14.4 0.354 0.181 0.336
52.6 ± 25.1
re logarithmically transformed before statistical testing to meet the assumption
ear regression, adjusted for age, gender, smoking, BMI, sICAM1 and MMP9
parison between AA and AC genotypes.
Table 3 Association of SELE locus haplotypes with MMP9 level (adjusted for age, gender, BMI, and smoking)
SNP1 SNP 2 SNP 3 SNP 4 SNP 5 SNP 6 SNP 7 Frequency Coef SE P value Adjusted
P value
H1 A A A A A G C 0.2542 -0.0514 0.0227 0.0234 0.0819
H2 G G A G A G T 0.2266 0.0512 0.0190 0.0070 0.0490
H3 G G A G C G C 0.2080 -0.0112 0.0200 0.5746 0.8044
H4 A A A G A A C 0.1384 0.0144 0.0221 0.5144 0.9002
H5 G A A G A G C 0.0651 -0.0086 0.0310 0.7822 0.7822
H6 A A A G A G C 0.0592 -0.0261 0.0352 0.4572 1
H7 G G A G A G C 0.0484 -0.0167 0.0370 0.6524 0.7611
SNP1: rs10800469, SNP2: rs3917406, SNP3: rs5361, SNP4: rs3917412, SNP5: rs2179172, SNP6: rs3917419, SNP7:rs5368. Multiple linear regression, adjusted for age,
gender, smoking and BMI. Adjusted P values were computed by the false discovery rate method.
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interactive effects of sICAM1 and MMP9 levels on
the association between the SELE gene polymorph-
isms and sE-selectin level. By multivariate analysis
with sICAM1 and MMP9 levels included for analysis,
significant associations of rs3917406 was found with
sE-selectin level (P = 0.005) (Table 2). The association
also remained statistically significant after multiple
comparisons adjustment (FDR P = 0.031) (Table 2).
Subgroup analysis revealed association of SELE SNP
rs10800469 with sE-selectin only in the highest quar-
tile of MMP9 levels (66.0 ± 38.7 vs. 48.0 ± 18.4 mg/dL,
AA + AG vs. GG genotypes, P = 0.002). Interaction
analysis revealed interaction of SELE genotypes and
MMP9 levels on sE-selectin levels (interaction P =
0.023) (Figure 1). Haplotype analysis showed two hap-
lotypes, AAAAAGC and GGAGCGC, were associated
with sE-selectin levels (P = 0.0073 and P = 0.0425, re-
spectively) (Table 5). However, after multiple compari-
sons adjustment, the association of GGAGCGC
became insignificant; whereas the apparent association
between haplotype AAAAAGC and sE-selectin levels
became borderline significant (FDR P = 0.0511).
Discussion
The present investigation analyzed the association of
genetic variants of the SELE gene with serumTable 4 MMP9 levels: stepwise linear regression analysis,
including genotype
Variable Beta R2a P value
Current smoker 0.165 0.054 < 0.001
rs5368 TT genotype 0.168 0.083 < 0.001
rs2274756 AA genotype 0.110 0.098 0.009
Fibrinogen 0.119 0.108 0.006
Age -0.124 0.118 0.004
Gender -0.090 0.127 0.029
aCumulative R2. Multiple linear regression, adjusted for age, gender, smoking
status, BMI, fibrinogen, fasting plasma glucose, and MMP9 rs2274756
genotype.inflammatory marker levels. The results showed that, in
addition to previously reported MMP9 genotypes, the
SELE gene is the second locus that is significantly asso-
ciated with MMP9 level in Taiwanese individuals. The
association of SELE genotypes/haplotypes with MMP9
level is significant after the adjustment of other inde-
pendent factors including age, gender, smoking status, fi-
brinogen levels, and MMP9 genotypes. To the best of
our knowledge, this is the first investigation revealing
that the genetic determinants of MMP9 levels may in-
clude a cellular adhesive molecule locus. Further, SELE
genotypes/haplotypes are independently associated with
sE-selectin levels, especially after the adjustment of
sICAM1 and MMP9 levels. Interaction analysis also
revealed an interactive effect of MMP9 level on the asso-
ciation of SELE genotypes with sE-selectin level. These
results provide further evidence of the close relationship
between cellular adhesive molecules and matrix
metalloproteinases.
The association between cellular adhesive molecules
and matrix metalloproteinases has been reported previ-
ously. Aoudjit et al. [29] demonstrated that firm ad-
hesion of T lymphoma cells to endothelial cells
participates in the production of MMP9 in both cell
types through bi-directional signaling pathways, and
identified ICAM-1/LFA-1 as a key interaction in the
up-regulation of MMP9 in T lymphoma cells. MMP9
also cleaved membrane ICAM1 in an in vitro model,
which may result in increased sICAM1 [30]. Although
direct evidence linking E-selectin and MMP9 molecules
is absent, there are several possibilities for the involve-
ment of the SELE gene in the signaling pathways affect-
ing gene expression and the serum level of MMP9. First,
both E-selectin and MMP9 have been shown to be
involved in the process of trans-endothelial migration
(TEM) of leukocytes and cancer cells. Endothelial
E-selectin is quickly and transiently expressed following
a challenge by proinflammatory stimuli and plays a pi-
votal role in mediating cell-cell interactions between
breast cancer cells, colon carcinoma cells, leukocytes,
Figure 1 Interactive effect of MMP9 levels on the association between rs10800469 and sE-selectin levels. After adjusting for clinical
covariates, minor allele of rs10800469 of the SELE gene was found to be associated with decreased sE-selectin levels, predominantly in highest
quartile of MMP9 levels subjects (P = 0.002). Interaction analysis revealed an interaction of MMP9 levels with the rs10800469 genotype (interaction
P = 0.023, after the adjustment of age, gender, BMI, smoking, sICAM1 and MMP9).
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ing on MMP9 function in vitro also provided a compelling
story implicating MMP9 as a rate-limiting extra-cellular
protease involved in cell migration across basement mem-
branes, a process that has been found to be orchestrated
by an ever-increasing number of molecules, including
selectins, integrins, and their ligands on the endothe-
lium that mediate rolling, firm adhesion, and diapedesis
[35-37]. Second, studies on endothelial signaling by ad-
hesive molecules and the concomitant analysis of asso-
ciated adapter proteins have been most successful for
E-selectin and ICAM-1. There is ample evidence for
the signal capacity of E-selectin, both towards the actin
cytoskeleton as well as to p42 MAPK/ERK activation
and the induction of c-fos [38-40]. MMP9, an inducible
enzyme, can be expressed in a number of cells under
the action of TNF-α, IL-1β, PDGF, and some other
growth factors. This expression has been shown to be
mediated via ERK1/2, p38 MAPK, and/or JNK signal
transduction pathways [41-43]. Third, both E-selectinTable 5 Association of SELE locus haplotypes with sE-selectin
and MMP9)
SNP 1 SNP 2 SNP 3 SNP 4 SNP 5 SNP 6 SNP
H1 A A A A A G C
H2 G G A G A G T
H3 G G A G C G C
H4 A A A G A A C
H5 G A A G A G C
H6 A A A G A G C
H7 G G A G A G C
SNP1: rs10800469, SNP2: rs3917406, SNP3: rs5361, SNP4: rs3917412, SNP5: rs2179172
gender, smoking, BMI, sICAM1 and MMP9 levels. Adjusted P values were computedand MMP9 have been shown to be involved in cancer-
cell invasion and metastasis. For a long time, the pro-
teolytic remodeling of extracellular matrix by MMPs,
serine proteases, and cathepsins was considered to be a
critical determinant of tumor cell invasiveness [44].
Thus, further studies involving direct analysis of the
interaction between E-selectin and MMP9 molecules
using in vitro models may help us to elucidate the role
of E-selectin on MMP9 expression.
Previous studies on the association between SELE
SNPs and sE-selectin levels have been controversial.
Chen et al. [15] revealed significant association of SELE
haplotypes with sE-selectin level in a Chinese popula-
tion. In a genome-wide association study, Paterson et al.
[17] found no evidence (probability value < 0.01) of
association between SNPs in or near the SELE gene and
sE-selectin levels. After analyzing 628 individuals from
different ethnic populations, Miller et al. [16] found no
evidence of association between the SELE S128R poly-
morphism and circulating sE-selectin levels. Our datalevel (adjusted for age, gender, BMI, smoking, sICAM1
7 Frequency Coef SE P value Adjusted P value
0.2542 0.0421 0.0157 0.0073 0.0511
0.2266 -0.0167 0.0133 0.2072 0.3626
0.2080 -0.0281 0.0139 0.0425 0.1487
0.1384 0.0255 0.0152 0.0935 0.2182
0.0651 -0.0175 0.0213 0.4124 0.5774
0.0592 0.0070 0.0242 0.7725 0.9012
0.0484 -0.0066 0.0256 0.7968 0.7968
, SNP6: rs3917419, SNP7:rs5368. Multiple linear regression, adjusted for age,
by the false discovery rate method.
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sE-selectin levels only in the highest quartile of MMP9
levels. Proteolytic cleavage of cellular adhesive molecules
on the cell membrane by proteases has been reported
before, however, it is unknown if the membrane E-
selectin molecule can be cleaved by MMP9. Significant
associations between sE-selectin and MMP9 levels were
noted in our study, suggesting a possible interaction be-
tween these two molecules. Further study is necessary to
elucidate the role of MMP9 on sE-selectin level.
Some limitations of our study deserve consideration.
One limitation of the study is the relatively low number
of subjects genotyped; replication in a second cohort
would improve the strength of the study. Furthermore,
only seven of the SELE SNPs were analyzed, and the in-
complete genotyping may not represent all of the haplo-
types in the SELE gene. Another limitation of this study
is its cross-sectional design, which could only draw lim-
ited inferences with regard to the relationships between
exposure and outcome. After the use of FDR for mul-
tiple testing corrections, only few SELE genetic variances
remained significantly associated with MMP9 or sE-
selectin level and the association between haplotypes on
MMP9 or sE-selectin levels became marginal. Therefore,
cautious and conservative interpretation of the data is
needed. Independent association studies with larger
sample sizes and more complete genotyping, especially
using a prospective design, are needed to confirm these
results before any definitive conclusions can be drawn.
Conclusions
In conclusion, our data revealed for the first time that
SELE SNPs are independently associated with MMP9
levels, in addition, SELE gene variants interacted with
MMP9 levels for the association with sE-selectin levels
in Taiwanese individuals. The findings have implications
for the prediction of inflammation-related disorders.
Further studies of the interrelationship between cellular
adhesive molecules and matrix metalloproteinases are
needed to confirm MMP9 levels as a possible link be-
tween SELE genotypes/haplotypes and inflammation-
related disorders.
Additional file
Additional file 1: Table S1. Primer sequences and restriction enzyme
(RE) used in SELE gene polymorphisms. S2. Linkage disequilibrium
between SELE genetic polymorphisms.
Abbreviations
SNPs: Single nucleotide polymorphisms; BMI: Body mass index; BP: Blood
pressure; CRP: C-reactive protein; HDL: High-density lipoprotein; LDL:
Low-density lipoprotein; sICAM1: Soluble intercellular adhesive molecule 1;
sE-selectin: Soluble E-selectin; MMP9: Matrix metalloproteinase 9; TEM:
Trans-endothelial migration.Competing interests
The authors declare that they have no competing interests.
Authors' contributions
S W and L-A H participated in genotyping, performed statistical analysis and
drafted the manuscript. M-S T and H-H C prepared the DNA samples and
participated in genotyping. J-F L participated in sample collection and
prepared the DNA samples. Y-C S participated in ELISA assay. H-P C
performed and corrected statistical analysis. Y-L K supervised the study and
revised the manuscript. All authors read and approved the final manuscript.
Acknowledgements
This study was supported by a grant from the National Science Council,
Taiwan (NSC100-2314-B-303-010), a grant from Tzu Chi University (TCIRP
99001-04Y1-02) and grants from the Buddhist Tzu Chi General Hospital
(TCRD-I100-01-01 and TCRD-TPE-97-13) to Y.-L. Ko, and a grant from the
National Science Council, Taiwan (NSC 98-2314-B-182A-086) to L.-A. Hsu.
Author details
1Department of Life Science, Chinese Culture University, Taipei, Taiwan.
2Department of Medical Research, Buddhist Tzu Chi General Hospital, Taipei
Branch, Taipei, Taiwan. 3The First Cardiovascular Division, Department of
Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan. 4Chang
Gung University College of Medicine, Taipei, Taiwan. 5Division of Cardiology,
Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Taipei
branch, 289 Jianguo Road, Xindian City, Taipei 231, Taiwan. 6Department of
Laboratory Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan.
7Department of Neurology, University of California, San Francisco, USA.
8School of Medicine, Tzu Chi University, Hualien, Taiwan.
Received: 30 June 2012 Accepted: 20 November 2012
Published: 29 November 2012
References
1. Hansson GK: Immune mechanisms in atherosclerosis. Arterioscler Thromb
Vasc Biol 2001, 21:1876–1890.
2. Snoeck-Stroband JB, Postma DS, Lapperre TS, Gosman MM, Thiadens HA,
Kauffman HF, Sont JK, Jansen DF, Sterk PJ: Airway inflammation
contributes to health status in COPD: a cross-sectional study. Respir Res
2006, 7:140.
3. Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA,
Cummings SR, Harris TB, Shlipak MG: Kidney function and markers of
inflammation in elderly persons without chronic kidney disease: the
health, aging, and body composition study. Kidney Int 2007, 71:239–244.
4. Lind L: Circulating markers of inflammation and atherosclerosis.
Atherosclerosis 2003, 169:203–214.
5. Krabbe KS, Pedersen M, Bruunsgaard H: Inflammatory mediators in the
elderly. Exp Gerontol 2004, 39:687–699.
6. van Buul JD, Hordijk PL: Endothelial adapter proteins in leukocyte
transmigration. Thromb Haemost 2009, 101:649–655.
7. Roldán V, Marín F, Lip GY, Blann AD: Soluble E-selectin in cardiovascular
disease and its risk factors. A review of the literature. Thromb Haemost
2003, 90:1007–1020.
8. Ellsworth DL, Bielak LF, Turner ST, Sheedy PF 2nd, Boerwinkle E, Peyser PA:
Gender- and age-dependent relationships between the E-selectin S128R
polymorphism and coronary artery calcification. J Mol Med 2001,
79:390–398.
9. Andreotti F, Porto I, Crea F, Maseri A: Inflammatory gene polymorphisms
and ischaemic heart disease: review of population association studies.
Heart 2002, 87:107–112.
10. Flex A, Gaetani E, Papaleo P, Straface G, Proia AS, Pecorini G, Tondi P, Pola P,
Pola R: Proinflammatory genetic profiles in subjects with history of
ischemic stroke. Stroke 2004, 35:2270–2275.
11. Jilma B, Kovar FM, Hron G, Endler G, Marsik CL, Eichinger S, Kyrle PA:
Homozygosity in the single nucleotide polymorphism Ser128Arg in the
E-selectin gene associated with recurrent venous thromboembolism.
Arch Intern Med 2006, 166:1655–1659.
12. Podgoreanu MV, White WD, Morris RW, Mathew JP, Stafford-Smith M,
Welsby IJ, Grocott HP, Milano CA, Newman MF, Schwinn DA, Perioperative
Genetics and Safety Outcomes Study (PEGASUS) Investigative Team:
Wu et al. BMC Medical Genetics 2012, 13:115 Page 8 of 8
http://www.biomedcentral.com/1471-2350/13/115Inflammatory gene polymorphisms and risk of postoperative myocardial
infarction after cardiac surgery. Circulation 2006, 114:I275–I281.
13. Takei T, Iida A, Nitta K, Tanaka T, Ohnishi Y, Yamada R, Maeda S, Tsunoda T,
Takeoka S, Ito K, Honda K, Uchida K, Tsuchiya K, Suzuki Y, Fujioka T, Ujiie T,
Nagane Y, Miyano S, Narita I, Gejyo F, Nihei H, Nakamura Y: Association
between single-nucleotide polymorphisms in selectin genes and
immunoglobulin A nephropathy. Am J Hum Genet 2002, 70:781–786.
14. Chang YP, Liu X, Kim JD, Ikeda MA, Layton MR, Weder AB, Cooper RS, Kardia
SL, Rao DC, Hunt SC, Luke A, Boerwinkle E, Chakravarti A: Multiple genes
for essential-hypertension susceptibility on chromosome 1q. Am J Hum
Genet 2007, 80:253–264.
15. Chen H, Cui B, Wang S, Zhao Z, Sun H, Gu X, Zhao Y, Li X, Ning G:
The common variants of E-selectin gene in Graves’ disease. Genes Immun
2008, 9:182–186.
16. Miller MA, Kerry SM, Dong Y, Sagnella GA, Cook DG, Cappuccio FP:
Circulating soluble E-selectin levels and the Ser 128Arg polymorphism in
individuals from different ethnic groups. Nutr Metab Cardiovasc Dis 2005,
15:65–70.
17. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter
RE, Shen E, Mirea L, Bharaj B, Sun L, Bull SB, Diabetes Control and
Complications Trial/Epidemiology of Diabetes Interventions and
Complications Research Group: Genome-wide association identifies the
ABO blood group as a major locus associated with serum levels of
soluble E-selectin. Arterioscler Thromb Vasc Biol 2009, 29:1958–1967.
18. Bellosta S, Via D, Canavesi M, Pfister P, Fumagalli R, Paoletti R, Bernini F:
HMG-CoA reductase inhibitors reduce MMP-9 secretion by
macrophages. Arterioscler Thromb Vasc Biol 1998, 18:1671–1678.
19. Haffner SM, Greenberg AS, Weston WM, Chen H, Williams K, Freed MI: Effect
of rosiglitazone treatment on nontraditional markers of cardiovascular
disease in patients with type 2 diabetes mellitus. Circulation 2002,
106:679–684.
20. Marx N, Froehlich J, Siam L, Ittner J, Wierse G, Schmidt A, Scharnagl H,
Hombach V, Koenig W: Antidiabetic PPAR gamma-activator rosiglitazone
reduces MMP-9 serum levels in type 2 diabetic patients with coronary
artery disease. Arterioscler Thromb Vasc Biol 2003, 23:283–288.
21. Tan CE, Ma S, Wai D, Chew SK, Tai ES: Can we apply the National
Cholesterol Education Program Adult Treatment Panel definition of the
metabolic syndrome to Asians? Diabetes Care 2004, 27:1182–1186.
22. Wu TL, Tsao KC, Chang CP, Li CN, Sun CF, Wu JT: Development of ELISA
on microplate for serum C-reactive protein and establishment of
age-dependent normal reference range. Clin Chim Acta 2002,
322:163–168.
23. Chan EC, Chang CP, Wu TL, Wu JT: Enzymatic Assay of Homocysteine on
Microtiter Plate or a TECAN Analyzer Using Crude Lysate Containing
Recombinant Methionine -Lyase. Ann Clin Lab Sci 2005, 35:155–160.
24. Wu TL, Chen Tsai I, Chang PY, Tsao KC, Sun CF, Wu LL, Wu JT:
Establishment of an in-house ELISA and the reference range for serum
amyloid A (SAA). Complementarity between SAA and C-reactive protein
as markers of inflammation. Clinica Chimica Acta 2007, 376:72–76.
25. Hsu LA, Ko YL, Hsu KH, Ko YH, Lee YS: Genetic variations in the cholesteryl
ester transfer protein gene and high density lipoprotein cholesterol
levels in Taiwanese Chinese. Hum Genet 2002, 110:57–63.
26. Ko YL, Hsu LA, Hsu KH, Ko YH, Lee YS: The interactive effects of hepatic
lipase gene promoter polymorphisms with gender and obesity on
high-density-lipoprotein cholesterol levels in Taiwanese-Chinese.
Atherosclerosis 2004, 172:135–142.
27. Sole X, Guino E, Valls J, Iniesta R, Moreno V: SNPStats: a web tool for the
analysis of association studies. Bioinformatics 2006, 22:1928–1929.
28. Wu S, Hsu LA, Teng MS, Lin JF, Chang HH, Chang PY, Hu CF, Ko YL:
Association of matrix metalloproteinase 9 genotypes and cardiovascular
disease risk factors with serum matrix metalloproteinase 9
concentrations in Taiwanese individuals. Clin Chem Lab Med 2010,
48:543–549.
29. Aoudjit F, Potworowski EF, St-Pierre Y: Bi-directional induction of matrix
metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1
during T lymphoma/endothelial cell contact: implication of ICAM-1.
J Immunol 1998, 160:2967–2973.
30. Fiore E, Fusco C, Romero P, Stamenkovic I: Matrix metalloproteinase 9
(MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in
tumor cell resistance to natural killer cell-mediated cytotoxicity.
Oncogene 2002, 21:5213–5223.31. Laferriere J, Houle F, Taher MM, Valerie K, Huot J: Transendothelial
migration of colon carcinoma cells requires expression of E-selectin by
endothelial cells and activation of stress-activated protein kinase-2
(SAPK2/p38) in the tumor cells. J Biol Chem 2001, 276:33762–33772.
32. Aychek T, Miller K, Sagi-Assif O, Levy-Nissenbaum O, Israeli-Amit M,
Pasmanik-Chor M, Jacob-Hirsch J, Amariglio N, Rechavi G, Witz IP: E-selectin
regulates gene expression in metastatic colorectal carcinoma cells and
enhances HMGB1 release. Int J Cancer 2008, 123:1741–1750.
33. Tremblay PL, Huot J, Auger FA: Mechanisms by which E-selectin regulates
diapedesis of colon cancer cells under flow conditions. Cancer Res 2008,
68:5167–5176.
34. Zen K, Liu DQ, Guo YL, Wang C, Shan J, Fang M, Zhang CY, Liu Y: CD44v4 is
a major E-selectin ligand that mediates breast cancer cell
transendothelial migration. PLoS One 2008, 3:e1826.
35. Cernuda-Morollón E, Ridley AJ: Rho GTPases and leukocyte adhesion
receptor expression and function in endothelial cells. Circ Res 2006,
98:757–767.
36. Hordijk PL: Endothelial signalling events during leukocyte transmigration.
FEBS J 2006, 273:4408–4415.
37. van Buul JD, Kanters E, Hordijk PL: Endothelial signaling by Ig-like cell
adhesion molecules. Arterioscler Thromb Vasc Biol 2007, 27:1870–1876.
38. Tremblay PL, Auger FA, Huot J: Regulation of transendothelial migration
of colon cancer cells by E-selectin-mediated activation of p38 and ERK
MAP kinases. Oncogene 2006, 25:6563–6573.
39. Suzuki C, Kojima N: A Cholesterol-independent membrane microdomain
serves as a functional counter-receptor for E-selectin at the Colo201 cell
surface and initiates signalling on E-selectin binding. J Biochem 2007,
142:55–64.
40. Brábek J, Mierke CT, Rösel D, Veselý P, Fabry B: The role of the tissue
microenvironment in the regulation of cancer cell motility and invasion.
Cell Commun Signal 2010, 8:22.
41. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R:
IL-10 inhibits inflammation and attenuates left ventricular remodeling
after myocardial infarction via activation of STAT3 and suppression of
HuR. Circ Res 2009, 104:e9–e18.
42. Mendes Sdos S, Candi A, Vansteenbrugge M, Pignon MR, Bult H, Boudjeltia
KZ, Munaut C, Raes M: Microarray analyses of the effects of NF-kappaB or
PI3K pathway inhibitors on the LPS-induced gene expression profile in
RAW264.7 cells: synergistic effects of rapamycin on LPS-induced
MMP9-overexpression. Cell Signal 2009, 21:1109–1122.
43. Tyagi N, Gillespie W, Vacek JC, Sen U, Tyagi SC, Lominadze D: Activation of
GABA-A receptor ameliorates homocysteine-induced MMP-9 activation
by ERK pathway. J Cell Physiol 2009, 220:257–266.
44. van Kempen LC, Coussens LM: MMP9 potentiates pulmonary metastasis
formation. Cancer Cell 2002, 2:251–252.
doi:10.1186/1471-2350-13-115
Cite this article as: Wu et al.: Association of SELE genotypes/haplotypes
with sE-selectin levels in Taiwanese individuals: interactive effect of
MMP9 level. BMC Medical Genetics 2012 13:115.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
